Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection

Area of Science:

• Biochemistry
• Cell Biology
• Medical Imaging

Background:

• Hypoxic cells are crucial in cancer and require accurate detection.
• Nitroimidazoles are established hypoxia markers but require isotopic labeling.
• A new approach is needed for sensitive and specific hypoxia detection.

Purpose of the Study:

• To develop and characterize a novel hypoxia probe.
• To utilize an immunologically recognizable hapten for detection.
• To enable sensitive detection of hypoxic cells via immunochemical methods.

Main Methods:

• Synthesis of 7-(4'-(2-nitroimidazol-1-yl)-butyl)-theophylline, a novel hypoxia probe.
• Bioreduction of the nitroimidazole moiety leading to covalent binding of metabolites.
• Immunochemical staining using FITC-conjugated anti-serum for cell detection.
• Flow cytometry with DNA co-staining for single-cell analysis.
• Immunoperoxidase staining for localization in tumor sections.

Main Results:

• The novel probe successfully labels hypoxic cells through bioreduction.
• Immunochemical detection with FITC-conjugated anti-serum is effective.
• Flow cytometry allows for accurate cell analysis and debris exclusion.
• Immunoperoxidase staining visualizes hypoxic cell localization in tumor tissues.

Conclusions:

• The new theophylline-linked nitroimidazole probe is a viable tool for detecting hypoxic cells.
• This method offers sensitive and specific detection of hypoxia.
• The probe facilitates both flow cytometric and tissue-based analyses of hypoxic cells.